Results also show that reducing the Padcev dose at treatment initiation may benefit older patients with urothelial carcinoma, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback